Anticancer Potential of Thieno[2,3-d]pyrimidine Derivatives in Oral Carcinoma Models
Molecules · 23.01.2026 · 31 (3) · 397
DOI: 10.3390/molecules31030397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 23.01.2026. Verfasst von Ivan Iliev und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 25, 1113 Sofi…. Hauptthemen laut MEDLINE: Pyrimidines, Antineoplastic Agents, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, Bulgarian Ministry of Education and Science, National Science Fund of Bulgaria.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) remains a major therapeutic challenge due to aggressive progression, high recurrence, and limited selectivity of current treatments. In this study, a series of seven 4-amino-2-substituted tetrahydrobenzothieno[2,3-d]pyrimidines were evaluated for their cytotoxic, antiproliferative, and mechanistic effects against oral cancer cell lines with different metastatic potential (HSC-3 and SCC-9), alongside non-tumorigenic keratinocytes (HaCaTs). Several compounds demonstrated selective anticancer activity, with Compounds 5 and 6 showing the most favorable balance between potency and selectivity. Antiproliferative assays revealed effective inhibition of cancer cell growth, while clonogenic assays confirmed a pronounced reduction in long-term survival, particularly in highly metastatic HSC-3 cells. Mechanistic studies indicated that the anticancer effects are associated with S-phase cell cycle arrest, apoptosis induction, and profound disruption of the actin cytoskeleton. In silico ADME and drug-likeness analyses supported the lead-like properties of the most active derivatives. Overall, these findings identify thienopyrimidine derivatives as promising scaffolds for the development of targeted therapies against OSCC and warrant further optimization and in vivo evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 25, 1113 Sofia, Bulgaria.
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 21, 1113 Sofia, Bulgaria.
- Department of Organic Chemistry, Faculty of Chemical Technologies, University of Chemical Technology and Metallurgy, S8 Kliment Ohridski Blvd., 1756 Sofia, Bulgaria.
- Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Acad. G. Bonchev Str., Bl. 9, 1113 Sofia, Bulgaria.
ORCID-Profile: Ivan Iliev, Anelia Mavrova, Denitsa Yancheva, Aneliya Kostadinova, Severina Semkova, Iana Tsoneva, Biliana Nikolova
Förderung
- Bulgarian Science Fund
- Bulgarian Ministry of Education and Science
- National Science Fund of Bulgaria
Zitieren
APA
Iliev, I., Nesheva, A., Mavrova, A., Yancheva, D., Kostadinova, A., Semkova, S., Momchilova, A., Tsoneva, I., Staneva, G., & Nikolova, B. (2026). Anticancer Potential of Thieno[2,3-d]pyrimidine Derivatives in Oral Carcinoma Models. Molecules, 31(3), 397. https://doi.org/10.3390/molecules31030397
Vancouver
Iliev I, Nesheva A, Mavrova A, Yancheva D, Kostadinova A, Semkova S, et al. Anticancer Potential of Thieno[2,3-d]pyrimidine Derivatives in Oral Carcinoma Models. Molecules. 2026;31(3):397. doi:10.3390/molecules31030397
BibTeX
@article{Iliev2026,
author = {Iliev, Ivan and Nesheva, Aleksandrina and Mavrova, Anelia and Yancheva, Denitsa and Kostadinova, Aneliya and Semkova, Severina and Momchilova, Albena and Tsoneva, Iana and Staneva, Galya and Nikolova, Biliana},
title = {Anticancer Potential of Thieno[2,3-d]pyrimidine Derivatives in Oral Carcinoma Models},
journal = {Molecules},
year = {2026},
volume = {31},
number = {3},
pages = {397},
doi = {10.3390/molecules31030397}
}
EUVIMED